Search

everythinglearnresearchcommunity

for

Search:↓

The treatment changed hormone levels and increased sexual behavior in female capuchin monkeys.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Applying estradiol to skin causes local changes but not cancer.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Estradiol gel can cause hair loss in dogs.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.